Alain R. Simard, PhD
NOSM University 935 Ramsey Lake Road Sudbury, ON P3E 2C6 Phone: 705-662-7196 Email: asimard@nosm.ca |
Associate Professor, Medical Sciences Division, NOSM University Core Faculty Member, Biomolecular Sciences Graduate Program, Laurentian University Cross-appointed, Chemistry and Biochemistry Department, Laurentian University Adjunct Professor, Département de chimie et biochimie, Université de Moncton |
Education/Training
2016-2017 |
Associate Professor, Département de chimie et biochimie, et Centre de formation médicale du Nouveau-Brunswick Université de Moncton |
2011-2016 |
Assistant Professor, Département de chimie et biochimie, et Centre de formation médicale du Nouveau-Brunswick Université de Moncton |
2007-2011 |
Postdoctoral fellow, Neurochemistry Barrow Neurological Institute, Phoenix, Arizona |
2006-2007 |
Postdoctoral fellow, Developmental Neurobiology The Salk Institute for Biological Studies, San Diego, California |
2003-2006 |
Ph.D. in Physiology-Endocrinology Université Laval, Québec City, Québec |
2000-2002 |
M.Sc. in Chemistry Laurentian University, Sudbury, Ontario |
1996-2000 |
B.Sc. in Biochemistry Laurentian University, Sudbury, Ontario |
Research Investigations
My research program aims to provide critical insights into how the body naturally controls inflammation, by using a multidisciplinary and collaborative approach to study emerging neuro-immune crosstalk mechanisms. For instance, it is established that nicotinic acetylcholine receptors (nAChRs) can regulate inflammation. However, little is known regarding the systemic, cellular, pharmacological, and molecular mechanisms involved in nAChR-dependent immune regulation. My current research focuses on identifying the mechanisms by which acetylcholine is used to communicate with nAChRs expressed by immune cells, thereby mediating their functions. To do so, we will:
ExpertiseImmunology, neuroimmunology, immune regulation, myeloid cells, neurodegenerative diseases, inflammatory diseases, cholinergic system, flow cytometry, animal models of disease. |
Selected Publications
B. Han, C. Zhang, S. Liu, Y. Xia, H. Sun, Z. Gong, AR Simard, Q. Liu, J. Hao. Non-neuronal cholinergic activity is potentiated in myasthenia gravis. BMC Neurology. 2017, 17:28. PMID: 28178923 Jiang, W., St-Pierre, S., Roy, P., Morley, B. J., Hao, J., Simard, A. R. Infiltration of CCR2+Ly6ChighProinflammatory Monocytes and Neutrophils into the Central Nervous System are Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis. J.Immunol. 2016, 196(5):2095-108. PMID: 26810225 St-Pierre, S., Jiang, W., Champigny, C., LeBlanc, E., Morley, B. J., Hao, J., Simard, A. R. Nicotinic acetylcholine receptors modulate bone marrow-derived pro-inflammatory monocyte production and survival.PLOS ONE, 2016, Feb 29;11(2):e0150230. PMID: 26925951 Simard AR, Gan Y, St-Pierre S, Ariana Kousari, Varun Patel, Paul Whiteaker, Barbara J. Morley, Ronald J. Lukas, Fu-Dong Shi. Differential modulation of experimental autoimmune encephalomyelitis by alpha9*- and beta2*-nicotinic acetylcholine receptors. Immunol. Cell. Biol. 2013, 91:195–200. PMID: 23399696 Shi F-D., Hao JW, Abdelwahab M, Shi SX, Simard AR, Whiteaker P, Lukas R, Zhou K. Nicotinic receptor beta2 determines NK cell-dependent tumor metastasis. PLoS ONE 2013, 8(2): e57495. PMID: 23469004 Hao J.*, Simard AR*, Turner GH, Wu J, Whiteaker P, Lukas RJ, Shi F-D. Attenuation of CNS inflammatory responses by nicotine involves a7 and non-a7 nicotinic receptors. Exp. Neurol. 2011, 227(1):110-9. PMID: 20932827 |